Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "LAR1:lu ;conttype:(refereed);pers:(Borrebaeck Carl)"

Sökning: LAR1:lu > Refereegranskat > Borrebaeck Carl

  • Resultat 1-10 av 237
Sortera/gruppera träfflistan
  • Abayneh, Sisay A, et al. (författare)
  • Sensitivity of HIV-1 primary isolates to human anti-CD40 antibody-mediated suppression is related to co-receptor use
  • 2008
  • Ingår i: AIDS Research and Human Retroviruses. - Mary Ann Liebert, Inc.. - 0889-2229 .- 1931-8405. ; 24:3, s. 447-452
  • Tidskriftsartikel (refereegranskat)abstract
    • The effect of CD40 ligation on infection by HIV-1 primary isolates with different R5 phenotypes was evaluated with a novel set of anti-CD40 monoclonal antibodies originating from a human phage display library. Five human monoclonal anti-CD40 antibodies of IgG1 subtype characterized by the ability to activate B cells via CD40 were tested for induction of the CC-chemokines RANTES and MIP-1alpha and inhibition of HIV-1 replication in primary monocyte-derived macrophages (MDM). All activating anti-CD40 antibodies were able to induce CC-chemokines in MDM. We chose the most potent antibody, clone B44, for further experiments. This antibody had a suppressive effect on HIV-1 isolates of the R5 phenotype with limited use of CCR5/CXCR4 chimeric receptors. In comparison, HIV-1 isolates with broader use of CCR5/CXCR4 chimeric receptors or with CXCR4 use were less sensitive to anti-CD40-induced suppression. The results indicate that HIV-1 replication is inhibited by human anti-CD40 monoclonal antibodies through the mechanism of CC-chemokine induction. This effect is thus restricted to HIV-1 isolates sensitive to inhibition by CC-chemokines.
  • Albrekt, Ann-Sofie, et al. (författare)
  • Skin sensitizers differentially regulate signaling pathways in MUTZ-3 cells in relation to their individual potency
  • 2014
  • Ingår i: Bmc Pharmacology & Toxicology. - 1471-2210. ; 15
  • Tidskriftsartikel (refereegranskat)abstract
    • Due to the recent European legislations posing a ban of animal tests for safety assessment within the cosmetic industry, development of in vitro alternatives for assessment of skin sensitization is highly prioritized. To date, proposed in vitro assays are mainly based on single biomarkers, which so far have not been able to classify and stratify chemicals into subgroups, related to risk or potency.
  • Andreasson, Ulrika, et al. (författare)
  • B cell lymphomas express CX(3)CR1 a non-B cell lineage adhesion molecule.
  • 2008
  • Ingår i: Cancer Letters. - 0304-3835. ; 259:2, s. 138-145
  • Tidskriftsartikel (refereegranskat)abstract
    • To study the differential expression of cell membrane-bound receptors and their potential role in growth and/or survival of the tumor cells, highly purified follicular lymphoma cells were analyzed, using gene expression analysis, and compared to non-malignant B cell populations. Filtering the genome for overexpressed genes coding for cell membrane-bound proteins/receptors resulted in a hit list of 27 identified genes. Among these, we have focused on the aberrant over expression of CX(3)CR1, in different types of B cell lymphoma, as compared to non-malignant B cells. We show that CX(3)CR1, which normally is not expressed on B cells, is expressed both at the mRNA and protein level in several subtypes of lymphoma. CX(3)CR1 has also shown to be involved in the homing to specific tissues that express the ligand, CX(3)CL1, in breast and prostate cancer and may thus be involved in dissemination of lymphoma.
  • Andreasson, Ulrika, et al. (författare)
  • Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells.
  • 2009
  • Ingår i: American Journal of Hematology. - John Wiley & Sons Ltd. - 1096-8652 .- 0361-8609. ; 84, s. 803-808
  • Tidskriftsartikel (refereegranskat)abstract
    • Follicular lymphoma (FL) frequently transforms into the more aggressive diffuse large B cell lymphoma (DLBCL-tr), but no protein biomarkers have been identified for predictive or early diagnosis. Gene expression analyses have identified genes changing on transformation but have failed to be reproducible in different studies, reflecting the heterogeneity within the tumor tissue and between tumor samples. Gene expression analyses on Affymetrix Human Genome U133 Plus 2.0 arrays were performed, using flow cytometry sorted tumor cells derived from FL and transformed DLBCL. To identify molecular targets associated with the transformation, subsequent immunohistochemistry (IHC) analyses of the corresponding proteins were performed. Using highly purified cells, this study identified 163 genes, which were significantly deregulated during the transformation in a majority of cases. Among the upregulated transcripts, 13 genes were selected for validation using IHC, based on the availability of commercial antibodies, and galectin-3 and NEK2 proteins specifically identify DLBCL-tr, when compared with FL. We demonstrate that by purifying tumor cells through cell sorting, thereby reducing the heterogeneity due to infiltrating cells, it was possible to identify distinct differences between tumor entities rather than variations due to cellular composition. Galectin-3 and NEK2 both identified a subgroup of DLBCL-tr, and the function of these protein markers also suggests a biological role in the transformation process. Am. J. Hematol. 2010. (c) 2009 Wiley-Liss, Inc.
  • Andreasson, Ulrika, et al. (författare)
  • Identification of uniquely expressed transcription factors in highly purified B-cell lymphoma samples.
  • 2010
  • Ingår i: American Journal of Hematology. - 0361-8609 .- 1096-8652. ; 85:6, s. 418-425
  • Tidskriftsartikel (refereegranskat)abstract
    • Transcription factors (TFs) are critical for B-cell differentiation, affecting gene expression both by repression and transcriptional activation. Still, this information is not used for classification of B-cell lymphomas (BCLs). Traditionally, BCLs are diagnosed based on a phenotypic resemblance to normal B-cells; assessed by immunohistochemistry or flow cytometry, by using a handful of phenotypic markers. In the last decade, diagnostic and prognostic evaluation has been facilitated by global gene expression profiling (GEP), providing a new powerful means for the classification, prediction of survival, and response to treatment of lymphomas. However, most GEP studies have typically been performed on whole tissue samples, containing varying degrees of tumor cell content, which results in uncertainties in data analysis. In this study, global GEP analyses were performed on highly purified, flow-cytometry sorted tumor-cells from eight subgroups of BCLs. This enabled identification of TFs that can be uniquely associated to the tumor cells of chronic lymphocytic leukemia (CLL), diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), hairy cell leukemia (HCL), and mantle cell lymphoma (MCL). The identified transcription factors influence both the global and specific gene expression of the BCLs and have possible implications for diagnosis and treatment.
  • Andreasson, Ulrika, et al. (författare)
  • The human IgE-encoding transcriptome to assess antibody repertoires and repertoire evolution
  • 2006
  • Ingår i: Journal of Molecular Biology. - Elsevier. - 0022-2836. ; 362:2, s. 212-227
  • Tidskriftsartikel (refereegranskat)abstract
    • Upon encounter with antigen, the B lymphocyte population responds by producing a diverse set of antigen-specific antibodies of various isotypes. The vast size of the responding populations makes it very difficult to study clonal evolution and repertoire composition occurring during these processes in humans. Here, we have explored an approach utilizing the H-EPSILON-encoding transcriptome to investigate aspects of repertoire diversity during the season of antigen exposure. We show through sequencing of randomly picked transcripts that the sizes of patients' repertoires are relatively small. This specific aspect of the transcriptome allows us to construct evolutionary trees pinpointing features of somatic hypermutation as it occurs in humans. Despite the small size of the repertoires, they are highly diverse with respect to VDJ gene usage, suggesting that the H-EPSILON-encoding transcriptome is a faithful mimic of other class-switched isotypes. Importantly, it is possible to use antibody library and selection technologies to define the specificity of clonotypes identified by random sequencing. The small size of the H-EPSILON-encoding transcriptome of peripheral blood B cells, the simple identification of clonally related sets of genes in this population, and the power of library and selection technologies ensure that this approach will allow us to investigate antibody evolution in human B lymphocytes of known specificity. As H-EPSILON repertoires show many of the hallmarks of repertoires encoding other isotypes, we suggest that studies of this type will have an impact on our understanding of human antibody evolution even beyond that occurring in the IgE-producing B cell population.
  • Bjorck, E, et al. (författare)
  • High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma
  • 2005
  • Ingår i: Blood. - American Society of Hematology. - 0006-4971 .- 1528-0020. ; 105:7, s. 2908-2915
  • Tidskriftsartikel (refereegranskat)abstract
    • Substantial research has been dedicated to the study of the relationship between genetic mechanisms regulating cell functions in tumors and how those tumors respond to various treatment regimens. Because these mechanisms are still not well understood, we have chosen to study the genetic makeup of 57 tumor samples from patients with follicular lymphoma (FL). Our goal was to develop a prognostic tool, which can be used as an aid in determining FL patients with tumors genetically predisposed to a successful treatment with the CHOP (cyclophosphamide, vincristine, doxorubicin, prednisone) regimen. To select relevant genes, high-density oligonucleotide arrays were used. There were 14 genes highly expressed in FL patients that responded well to CHOP chemotherapy, and 11 of these were involved in G(2)/M transition of the cell cycle, in mitosis, or in DNA modulation. A high expression of CCNB1 (cyclin B1), CDC2, CDKN3A, CKS1B, ANP32E, and KIAA0101, but not of the proliferation-related antigen Ki-67, was associated with better survival rate in a univariate analysis. CCNB1 expression had an independent prognostic value when included in a multivariate analysis together with the 5 parameters of the follicular lymphoma international prognostic index.
  • Borrebaeck, Carl A K, et al. (författare)
  • Recombinant Antibody Microarray for Profiling the Serum Proteome of SLE.
  • 2014
  • Ingår i: Methods in Molecular Biology. - 1940-6029 .- 1064-3745. ; 1134, s. 67-78
  • Tidskriftsartikel (refereegranskat)abstract
    • Systemic lupus erythematosus (SLE) is a severe autoimmune connective tissue disease. Our current knowledge about the serum proteome, or serum biomarker panels, reflecting disease and disease status is still very limited. Affinity proteomics, represented by recombinant antibody arrays, is a novel, multiplex technology for high-throughput protein expression profiling of crude serum proteomes in a highly specific, sensitive, and miniaturized manner. The antibodies are deposited one by one in an ordered pattern, an array, onto a solid support. Next, the sample is added, and any specifically bound proteins are detected and quantified. The binding pattern is then converted into a relative protein expression map, or protein map, deciphering the composition of the sample at the molecular level. The methodology provides unique opportunities for delineating serum biomarkers reflecting SLE, thus paving the way for improved diagnosis, classification, and prognosis.
  • Borrebaeck, Carl (författare)
  • Advanced technologies and diagnostic spin-outs: an interview with Carl Borrebaeck.
  • 2015
  • Ingår i: Expert Review of Molecular Diagnostics. - Taylor & Francis. - 1473-7159 .- 1744-8352. ; 15:11, s. 1409-1410
  • Tidskriftsartikel (refereegranskat)abstract
    • Interview with Professor Carl Borrebaeck DSc by Claire Raison (Commissioning Editor) Professor Carl Borrebaeck DSc, is the Director of CREATE Health (Lund, Sweden), a translational cancer center, previous Vice President of Lund University and specializes in immunotechnology, diagnostics and treatments for cancer. He has had remarkable success in co-founding collaborative working groups and related spin-out companies based in Lund. Professor Borrebaeck also serves as a member of the editorial advisory board for Expert Review of Molecular Diagnostics. Here, Professor Borrebaeck talks to Expert Review of Molecular Diagnostics about his experience and what is next for cutting-edge technology in cancer diagnostics.
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 237
fritt online (42)
Typ av publikation
tidskriftsartikel (135)
annan publikation (83)
konferensbidrag (8)
forskningsöversikt (8)
bokkapitel (3)
Typ av innehåll
Wingren, Christer (98)
Lindstedt, Malin (39)
Ingvarsson, Johan (35)
Ek, Sara (27)
Ellmark, Peter (23)
visa fler...
Carlsson, Anders, (21)
Steinhauer, Cornelia (14)
Ohlin, Mats (13)
Uhlén, Mathias, (11)
Andreasson, Ulrika (11)
Jerkeman, Mats (10)
Dictor, Michael (10)
Larsson, Kristina, (10)
Lundberg, Kristina (10)
Dexlin, Linda (10)
Greiff, Lennart (9)
Jirström, Karin, (8)
Laurell, Thomas (7)
James, Peter (7)
Furebring, Christina (7)
Olsson, Niclas (7)
Fernö, Mårten (6)
Sturfelt, Gunnar (6)
Marko-Varga, György (6)
Borrebaeck, Carl A K (6)
Högerkorp, Carl-Magn ... (6)
Johansson Lindbom, B ... (6)
Malmborg Hager, Ann- ... (6)
Karlsson, Fredrik, (5)
Johansson, Henrik (5)
Baldetorp, Bo (5)
Olsson, Håkan (5)
Rosenquist, Richard, (5)
Albrekt, Ann-Sofie (5)
Broos, Sissela (5)
Gustavsson, Elin (5)
Vallkil, Jacob (5)
Dexlin Mellby, Linda (5)
Ressine, Anton (5)
Fransson, Johan (5)
Persson, Erik (4)
Salford, Leif (4)
Hansson, Stefan (4)
Korsgren, Magnus (4)
Peterson, Carsten (4)
Ingvarsson, Sigurdur (4)
Akagi, Takami (4)
Akashi, Mitsuru (4)
Kristensson, Malin (4)
visa färre...
Lunds universitet (237)
Uppsala universitet (10)
Karolinska Institutet (8)
Kungliga Tekniska Högskolan (8)
RISE (3)
Göteborgs universitet (2)
visa fler...
Sveriges Lantbruksuniversitet (1)
Linköpings universitet (1)
Chalmers tekniska högskola (1)
visa färre...
Engelska (237)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (222)
Naturvetenskap (22)
Teknik (12)
Lantbruksvetenskap (3)


pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy